Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5
Darshana Kadekar, Rasmus Agerholm, John Rizk, Heidi A. Neubauer, Tobias Suske, Barbara Maurer, Monica Torrellas Viñals, Elena M. Comelli, Amel Taibi, Richard Moriggl, Vasileios Bekiaris
Darshana Kadekar, Rasmus Agerholm, John Rizk, Heidi A. Neubauer, Tobias Suske, Barbara Maurer, Monica Torrellas Viñals, Elena M. Comelli, Amel Taibi, Richard Moriggl, Vasileios Bekiaris
View: Text | PDF
Research Article Immunology

The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5

  • Text
  • PDF
Abstract

IL-17–producing RORγt+ γδ T cells (γδT17 cells) are innate lymphocytes that participate in type 3 immune responses during infection and inflammation. Herein, we show that γδT17 cells rapidly proliferate within neonatal lymph nodes and gut, where, upon entry, they upregulate T-bet and coexpress IL-17, IL-22, and IFN-γ in a STAT3- and retinoic acid–dependent manner. Neonatal expansion was halted in mice conditionally deficient in STAT5, and its loss resulted in γδT17 cell depletion from all adult organs. Hyperactive STAT5 mutant mice showed that the STAT5A homolog had a dominant role over STAT5B in promoting γδT17 cell expansion and downregulating gut-associated T-bet. In contrast, STAT5B preferentially expanded IFN-γ–producing γδ populations, implying a previously unknown differential role of STAT5 gene products in lymphocyte lineage regulation. Importantly, mice lacking γδT17 cells as a result of STAT5 deficiency displayed a profound resistance to experimental autoimmune encephalomyelitis. Our data identify that the neonatal microenvironment in combination with STAT5 is critical for post-thymic γδT17 development and tissue-specific imprinting, which is essential for infection and autoimmunity.

Authors

Darshana Kadekar, Rasmus Agerholm, John Rizk, Heidi A. Neubauer, Tobias Suske, Barbara Maurer, Monica Torrellas Viñals, Elena M. Comelli, Amel Taibi, Richard Moriggl, Vasileios Bekiaris

×

Figure 1

STAT5 is necessary for the neonatal expansion of γδT17 cells.

Options: View larger image (or click on image) Download as PowerPoint
STAT5 is necessary for the neonatal expansion of γδT17 cells.
Flow cytom...
Flow cytometric analysis of γδ T cells in RORγtCRE-STAT5F/F (Cre+) and littermate control mice (Cre−). In graphs, each symbol represents a mouse, and lines represent the median. **P < 0.01, ***P < 0.001, ****P < 0.0001 using Mann-Whitney test. (A) Expression of CD27 and CD44 in order to identify CD27−CD44+ γδT17 cells in the LN. Numbers indicate percentage of CD27−CD44+ within the γδ T cell compartment. (B) Numbers of γδT17 cells in the LN (staining as in A) and skin and frequency of IL-17A–producing cells within the LN γδ T cell compartment. In the skin, γδT17 cells were identified as CD45+CD3loVγ5−TCRβ−TCRγδ+CCR6+. (C) Numbers of CD27+ γδ T cells in the LN and frequency of IFN-γ–producing cells within the LN γδ T cell compartment. (D) Numbers of CD27−CD44+ γδT17 cells in 2- and 7-day-old thymi. (E) Numbers of CD27−CD44+ γδT17 cells in 7- and 14-day-old LN. (F) Frequency of Ki67+RORγt+ or Ki67+CCR6+ cells within the CD44+TCRγδ+ compartment in 7- and 14-day-old LN. (A–C) n = 14–16 mice, 5 experiments; (D) n = 11 (d2) and 9 (d7) Cre− mice and 23 (d2) and 12 (d7) Cre+ mice, 3 experiments; (E) n = 9 (d7) and 4 (d14) Cre− mice and 10 (d7) and 10 (d14) Cre+ mice, 3 experiments; (F) n = 7 (d7) and 6 (d14) Cre− mice and 13 (d7) and 10 (d14) Cre+ mice, 3 experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts